Mammography News and Research

RSS

A mammogram is a safe test used to look for any problems with a woman's breasts. The test uses a special, low-dose x-ray machine to take pictures of both breasts. The results are recorded on x-ray film or directly onto a computer for a radiologist to examine.

Mammograms allow the doctor to have a closer look for breast lumps and changes in breast tissue. They can show small lumps or growths that a doctor or woman may not be able to feel when doing a clinical breast exam. "Mammography" is the best screening tool that doctors have for finding breast cancer.

If a lump is found, your doctor may order other tests, such as ultrasound or a biopsy--a test where a small amount of tissue is taken from the lump and area around the lump. The tissue is sent to a lab to look for cancer or changes that may mean cancer is likely to develop. Breast lumps or growths can be benign (not cancer) or malignant (cancer). Finding breast cancer early means that a woman has a better chance of surviving the disease. There are also more choices for treatment when breast cancer is found early.

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.

1 Jun 2010

Women who undergo bilateral oophorectomy tend to have smaller tumors

More than half a million women in the United States undergo a hysterectomy each year and approximately half of those surgeries include removal of the ovaries. Researchers know that removing a woman's ovaries is associated with a reduction in the risk of developing breast cancer, but it has not been clear whether those cancers that do arise in these women differ from breast cancers in the general population.

29 May 2010

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

In a recent study presented at the American Association of Cancer Research Annual Meeting in Washington, DC, researchers at the University of Texas MD Anderson Cancer Center showed that Positron Emission Mammography (PEM) helps evaluate response to neoadjuvant chemotherapy.

28 May 2010

Study finds improvement in detection of breast cancer in mammograms over 9-year period

Researchers analyzing 2.5 million screening mammograms performed on nearly one million women found discrimination of cancerous from non-cancerous lesions improved over a nine-year period. Results of the study are published in the online edition of the journal Radiology.

27 May 2010

Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVue system

The Barbara Ann Karmanos Cancer Institute announced today that its spin-off company Delphinus Medical Technologies, LLC, has secured $8 million in venture capital to start the commercialization process of SoftVue, an alternative to mammography.

25 May 2010

DMS Health Technologies receives Omega's 2009 NorthFace ScoreBoard Award

DMS Health Technologies announces that it was honored for delivering 'world-class' customer service as a recipient of Omega's 2009 NorthFace ScoreBoard Award for the second consecutive year at the SCORE Conference 2010 on April 29. As rated by its own customers, DMS Health Technologies achieved excellence in customer satisfaction during the prior calendar year for mobile MRI, CT, PET/CT, nuclear medicine, digital mammography, cardiac/angio and bone densitometry services and interim solution rentals; and diagnostic imaging equipment service.

20 May 2010

Canadian Cancer Statistics 2010 focuses on care, support for dying patients

The type and quality of care and services to ensure a cancer patient dies with dignity in the setting of their choice depends on where the person lives in Canada, according to a special report about end-of-life care in Canadian Cancer Statistics 2010, released today by the Canadian Cancer Society.

20 May 2010

Tianyin third-quarter revenue up 60%

Tianyin Pharmaceutical Co., Inc.,, a biopharmaceutical company that specializes in the modernized traditional Chinese medicine and branded generics today announced fiscal results for its third quarter ended March 31, 2010.

12 May 2010

Radnet first-quarter revenue down, net loss up

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 190 fully-owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2010.

10 May 2010

Swedish Cancer Institute, Elekta renew partnership to continue flow of technology, services to cancer patients

Swedish Cancer Institute and Elekta launch renewed partnership agreement to continue the flow of world-class technology, services to cancer patients in the Pacific Northwest and beyond.

From Elekta 6 May 2010

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

The National Institutes of Health has awarded $10.24 million to Fred Hutchinson Cancer Research Center to lead a five-year study that aims to understand and prevent breast cancer disparities in Hispanic women.

4 May 2010

NIH awards UIC $10M grant to study health disparities among underserved, minority women with breast cancer

A $9.6 million grant from the National Institutes of Health has been awarded to the University of Illinois at Chicago to study access to care and health disparities among underserved and minority women with breast cancer in Chicago.

4 May 2010

BSGI improves breast cancer detection

A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy.

3 May 2010

Obese women more likely to have breast cancer at later stage: Study

Obese women are more likely to have breast cancer detected at a later stage and to have lymph node metastases when diagnosed than women who are not obese, according to a study presented this week at the Annual Meeting of the American Society of Breast Surgeons.

3 May 2010

University of Bern purchases Sectra's SyMRI software for synthetic MR

Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.

26 Apr 2010

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Citing strong interest and engagement from city employees as well as requests from school district members, the city of Manchester and Anthem Blue Cross and Blue Shield in New Hampshire announced today enhancements to the innovative Compass SmartShopper Program as well as the addition of Manchester school district employees to the project.

23 Apr 2010

Additional training may benefit physicians who interpret screening mammograms

A multi-site study led by an Oregon Health & Science University Knight Cancer Institute researcher has identified set criteria that could be used to help identify physicians who might benefit from additional training in interpreting screening mammograms.

23 Apr 2010

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Manhattan Scientifics, Inc. announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.

22 Apr 2010

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Women who have a breast density of 75 percent or higher on a mammogram have a risk of breast cancer that is four to five times greater than that of women with little or no density, making mammographic breast density one of the strongest biomarkers of breast cancer risk.